Skip to content

MDT

Medtronic plc

Revenue by segment

FY2026, ended Apr 24, 2026

Earlier:

Segments by fiscal year

Segments by fiscal year
Line, in USDFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Reportable segment net sales33.1B30.7B29.7B30.7B31.0B—————————
Cardiovascular
14.0B12.5B11.8B11.5B11.4B10.8B10.5B11.5B——————
Neuroscience
10.3B9.8B9.4B9.0B8.8B8.2B7.7B8.2B——————
Medical Surgical
8.82B8.41B8.42B7.99B8.47B8.74B8.35B8.48B——————
Other Operating Segments, Including Diabetes3.25B2.89B2.71B———————————
Diabetes
3.11B2.76B2.49B2.26B2.34B2.41B2.37B2.39B2.14B1.93B1.86B1.76B1.66B1.53B
Other operating segment, misc
135M—————————————
Other Operating Segments
—138M222M495M727M—————————
Other Adjustments39M−90M————————————
————————27.8B27.8B27.0B18.5B15.3B15.1B
Total36.4B33.5B32.4B31.2B31.7B30.1B28.9B30.6B30.0B29.7B28.8B20.3B17.0B16.6B